IP Library Granted Patent US 11,998,457
Granted Patent B2
US 11,998,457 · App. 17/308,725 · Granted Jun 4, 2024

Implant trial with radiographically visible indicium

Inventors: Adam MacMillan (St. Louis, MO); Gerhart Suppiger (St. Louis, MO); Brett Smith (St. Louis, MO)
Assignee: CORELINK, LLC
A61F2/4684A61F2/442A61F2002/3008A61F2002/30617
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,998,457
App. No.
17/308,725
Granted
Jun 4, 2024
Kind
B2
Abstract

An implant trial includes a trial body and an indicium disposed in the trial body. The trial body is positionable in a subject. The indicium is designed and constructed to indicate a parameter of the implant trial. The indicium is radiographically visible when the trial body is positioned in the subject. The implant trial may be a trial spacer for vertebrae.

Claims (17)

1. A trial spacer comprising:

a spacer body configured to be positioned between vertebrae of a subject; and

depth indicia disposed in the spacer body, each of the depth indicia comprising a numerical value and designed and constructed to indicate a distance from a distal end of the spacer body to a corresponding one of the depth indicia, wherein the depth indicia are radiographically visible when the spacer body is positioned between the vertebrae of the subject, wherein the depth indicia are enclosed within the spacer body and not visible without radiographic imaging, and wherein a portion of the spacer body is more radiolucent than the depth indicia so that the depth indicia are radiographically visible.

2. The trial spacer set forth in claim 1 , wherein the spacer body defines an internal chamber, wherein the depth indicia are disposed in the internal chamber.

3. The trial spacer set forth in claim 1 , wherein each of the depth indicia is designed and constructed to be visible when radiographically viewed in an anterior-posterior view.

4. The trial spacer set forth in claim 1 , further comprising sizing indicium indicating a size of the trial spacer, wherein the sizing indicium is a numerical value.

5. The trial spacer set forth in claim 4 , wherein the sizing indicium is visible without radiographic imaging.

6. The trial spacer set forth in claim 4 , wherein the spacer body defines a window extending through the spacer body, wherein the sizing indicium is visible through the window without radiographic imaging.

7. The trial spacer set forth in claim 1 , wherein the depth indicia indicates depth of insertion of the trial spacer between the two vertebrae in use.

8. The trial spacer set forth in claim 1 , wherein the spacer body includes a superior wall, an inferior wall, an anterior wall, and a posterior wall, wherein the depth indicia is radiographically visible through at least one of the anterior wall and the posterior wall.

9. The trial spacer set forth in claim 1 , further comprising depth markers on the spacer body, wherein each of the depth indicia corresponds to one of the depth markers, each depth marking defining a notch on the spacer body.

10. A method of making a trial spacer of claim 1 , the method comprising forming the spacer body and the depth indicia by additive manufacturing so that the spacer body and the depth indicia are formed as an integrally formed, one-piece component.

11. A trial spacer comprising:

a spacer body configured to be positioned between vertebrae of a subject; and

a sizing indicium disposed in the spacer body, the sizing indicium comprising a numerical value and designed and constructed to indicate a size of the trial spacer,

wherein the sizing indicium is radiographically visible and readable when the spacer body is positioned between the vertebrae of the subject, and

wherein the sizing indicium is disposed in a window extending through the spacer body such that the sizing indicium is also visible and readable without radiographic imaging.

Assignments (3)
SECURITY INTEREST Recorded Jul 22, 2024
From: CORELINK, LLC
To: VARAGON CAPITAL PARTNERS AGENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 068045/0638 →
SECURITY INTEREST Recorded Jun 24, 2024
From: CORELINK, LLC
To: VARAGON CAPITAL PARTNERS AGENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 067820/0916 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2022
From: MACMILLAN, ADAM; SUPPIGER, GERHART; SMITH, BRETT
To: CORELINK, LLC
Reel/Frame 058975/0232 →
Continuity (2)
Provisional Application 63020126 · May 5, 2020
Related Publication 20210346176A1 · Nov 11, 2021
Cited By (1)
US 12,307,918